Global FIC Single-target Drugs Market Growth 2026-2032
The global FIC Single-target Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
FIC (First in Class) refers to a drug that is first-in-class and is created by gradually synthesizing candidate compounds from scratch by finding new drug targets, mechanisms of action, and molecular structures. Through repeated trials and screening, the drug is ultimately found to meet the requirements of both therapeutic effects and human safety (tolerance, pharmacokinetics).
United States market for FIC Single-target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for FIC Single-target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for FIC Single-target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key FIC Single-target Drugs players cover Pfizer, Johnson & Johnson, Merck, Roche, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?FIC Single-target Drugs Industry Forecast? looks at past sales and reviews total world FIC Single-target Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected FIC Single-target Drugs sales for 2026 through 2032. With FIC Single-target Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIC Single-target Drugs industry.
This Insight Report provides a comprehensive analysis of the global FIC Single-target Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIC Single-target Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global FIC Single-target Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIC Single-target Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIC Single-target Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of FIC Single-target Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global FIC Single-target Drugs market?
What factors are driving FIC Single-target Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIC Single-target Drugs market opportunities vary by end market size?
How does FIC Single-target Drugs break out by Type, by Application?
FIC (First in Class) refers to a drug that is first-in-class and is created by gradually synthesizing candidate compounds from scratch by finding new drug targets, mechanisms of action, and molecular structures. Through repeated trials and screening, the drug is ultimately found to meet the requirements of both therapeutic effects and human safety (tolerance, pharmacokinetics).
United States market for FIC Single-target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for FIC Single-target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for FIC Single-target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key FIC Single-target Drugs players cover Pfizer, Johnson & Johnson, Merck, Roche, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?FIC Single-target Drugs Industry Forecast? looks at past sales and reviews total world FIC Single-target Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected FIC Single-target Drugs sales for 2026 through 2032. With FIC Single-target Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIC Single-target Drugs industry.
This Insight Report provides a comprehensive analysis of the global FIC Single-target Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIC Single-target Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global FIC Single-target Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIC Single-target Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIC Single-target Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of FIC Single-target Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- ROR? Covalent Inhibitors
- Citron Inhibitors
- ALK2 Inhibitors
- GCN2 Agonists
- Others
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Johnson & Johnson
- Merck
- Roche
- Novartis
- BMS
- ImmunoGen
- Sanofi
- Immunocore
- Genentech
- Eli Lilly
- Agios
- Boehringer Ingelheim
- Gilead
- Mallinckrodt
- Phathom
- Dermavant Sciences
- Polarean lmaging
- Marinus
What is the 10-year outlook for the global FIC Single-target Drugs market?
What factors are driving FIC Single-target Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIC Single-target Drugs market opportunities vary by end market size?
How does FIC Single-target Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global FIC Single-target Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for FIC Single-target Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for FIC Single-target Drugs by Country/Region, 2021, 2025 & 2032
2.2 FIC Single-target Drugs Segment by Type
2.2.1 ROR? Covalent Inhibitors
2.2.2 Citron Inhibitors
2.2.3 ALK2 Inhibitors
2.2.4 GCN2 Agonists
2.2.5 Others
2.2.6 FIC Single-target Drugs Sales by Type
2.2.6.1 Global FIC Single-target Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global FIC Single-target Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global FIC Single-target Drugs Sale Price by Type (2021-2026)
2.3 FIC Single-target Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 FIC Single-target Drugs Sales by Application
2.3.4.1 Global FIC Single-target Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global FIC Single-target Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global FIC Single-target Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global FIC Single-target Drugs Breakdown Data by Company
3.1.1 Global FIC Single-target Drugs Annual Sales by Company (2021-2026)
3.1.2 Global FIC Single-target Drugs Sales Market Share by Company (2021-2026)
3.2 Global FIC Single-target Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global FIC Single-target Drugs Revenue by Company (2021-2026)
3.2.2 Global FIC Single-target Drugs Revenue Market Share by Company (2021-2026)
3.3 Global FIC Single-target Drugs Sale Price by Company
3.4 Key Manufacturers FIC Single-target Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers FIC Single-target Drugs Product Location Distribution
3.4.2 Players FIC Single-target Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIC SINGLE-TARGET DRUGS BY GEOGRAPHIC REGION
4.1 World Historic FIC Single-target Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global FIC Single-target Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global FIC Single-target Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic FIC Single-target Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global FIC Single-target Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global FIC Single-target Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas FIC Single-target Drugs Sales Growth
4.4 APAC FIC Single-target Drugs Sales Growth
4.5 Europe FIC Single-target Drugs Sales Growth
4.6 Middle East & Africa FIC Single-target Drugs Sales Growth
5 AMERICAS
5.1 Americas FIC Single-target Drugs Sales by Country
5.1.1 Americas FIC Single-target Drugs Sales by Country (2021-2026)
5.1.2 Americas FIC Single-target Drugs Revenue by Country (2021-2026)
5.2 Americas FIC Single-target Drugs Sales by Type (2021-2026)
5.3 Americas FIC Single-target Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC FIC Single-target Drugs Sales by Region
6.1.1 APAC FIC Single-target Drugs Sales by Region (2021-2026)
6.1.2 APAC FIC Single-target Drugs Revenue by Region (2021-2026)
6.2 APAC FIC Single-target Drugs Sales by Type (2021-2026)
6.3 APAC FIC Single-target Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe FIC Single-target Drugs by Country
7.1.1 Europe FIC Single-target Drugs Sales by Country (2021-2026)
7.1.2 Europe FIC Single-target Drugs Revenue by Country (2021-2026)
7.2 Europe FIC Single-target Drugs Sales by Type (2021-2026)
7.3 Europe FIC Single-target Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa FIC Single-target Drugs by Country
8.1.1 Middle East & Africa FIC Single-target Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa FIC Single-target Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa FIC Single-target Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa FIC Single-target Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of FIC Single-target Drugs
10.3 Manufacturing Process Analysis of FIC Single-target Drugs
10.4 Industry Chain Structure of FIC Single-target Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 FIC Single-target Drugs Distributors
11.3 FIC Single-target Drugs Customer
12 WORLD FORECAST REVIEW FOR FIC SINGLE-TARGET DRUGS BY GEOGRAPHIC REGION
12.1 Global FIC Single-target Drugs Market Size Forecast by Region
12.1.1 Global FIC Single-target Drugs Forecast by Region (2027-2032)
12.1.2 Global FIC Single-target Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global FIC Single-target Drugs Forecast by Type (2027-2032)
12.7 Global FIC Single-target Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer FIC Single-target Drugs Product Portfolios and Specifications
13.1.3 Pfizer FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson FIC Single-target Drugs Product Portfolios and Specifications
13.2.3 Johnson & Johnson FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck FIC Single-target Drugs Product Portfolios and Specifications
13.3.3 Merck FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche FIC Single-target Drugs Product Portfolios and Specifications
13.4.3 Roche FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis FIC Single-target Drugs Product Portfolios and Specifications
13.5.3 Novartis FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 BMS
13.6.1 BMS Company Information
13.6.2 BMS FIC Single-target Drugs Product Portfolios and Specifications
13.6.3 BMS FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BMS Main Business Overview
13.6.5 BMS Latest Developments
13.7 ImmunoGen
13.7.1 ImmunoGen Company Information
13.7.2 ImmunoGen FIC Single-target Drugs Product Portfolios and Specifications
13.7.3 ImmunoGen FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ImmunoGen Main Business Overview
13.7.5 ImmunoGen Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi FIC Single-target Drugs Product Portfolios and Specifications
13.8.3 Sanofi FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Immunocore
13.9.1 Immunocore Company Information
13.9.2 Immunocore FIC Single-target Drugs Product Portfolios and Specifications
13.9.3 Immunocore FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Immunocore Main Business Overview
13.9.5 Immunocore Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech FIC Single-target Drugs Product Portfolios and Specifications
13.10.3 Genentech FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly FIC Single-target Drugs Product Portfolios and Specifications
13.11.3 Eli Lilly FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Agios
13.12.1 Agios Company Information
13.12.2 Agios FIC Single-target Drugs Product Portfolios and Specifications
13.12.3 Agios FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Agios Main Business Overview
13.12.5 Agios Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim FIC Single-target Drugs Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Gilead
13.14.1 Gilead Company Information
13.14.2 Gilead FIC Single-target Drugs Product Portfolios and Specifications
13.14.3 Gilead FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Gilead Main Business Overview
13.14.5 Gilead Latest Developments
13.15 Mallinckrodt
13.15.1 Mallinckrodt Company Information
13.15.2 Mallinckrodt FIC Single-target Drugs Product Portfolios and Specifications
13.15.3 Mallinckrodt FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Mallinckrodt Main Business Overview
13.15.5 Mallinckrodt Latest Developments
13.16 Phathom
13.16.1 Phathom Company Information
13.16.2 Phathom FIC Single-target Drugs Product Portfolios and Specifications
13.16.3 Phathom FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Phathom Main Business Overview
13.16.5 Phathom Latest Developments
13.17 Dermavant Sciences
13.17.1 Dermavant Sciences Company Information
13.17.2 Dermavant Sciences FIC Single-target Drugs Product Portfolios and Specifications
13.17.3 Dermavant Sciences FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Dermavant Sciences Main Business Overview
13.17.5 Dermavant Sciences Latest Developments
13.18 Polarean lmaging
13.18.1 Polarean lmaging Company Information
13.18.2 Polarean lmaging FIC Single-target Drugs Product Portfolios and Specifications
13.18.3 Polarean lmaging FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Polarean lmaging Main Business Overview
13.18.5 Polarean lmaging Latest Developments
13.19 Marinus
13.19.1 Marinus Company Information
13.19.2 Marinus FIC Single-target Drugs Product Portfolios and Specifications
13.19.3 Marinus FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Marinus Main Business Overview
13.19.5 Marinus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global FIC Single-target Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for FIC Single-target Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for FIC Single-target Drugs by Country/Region, 2021, 2025 & 2032
2.2 FIC Single-target Drugs Segment by Type
2.2.1 ROR? Covalent Inhibitors
2.2.2 Citron Inhibitors
2.2.3 ALK2 Inhibitors
2.2.4 GCN2 Agonists
2.2.5 Others
2.2.6 FIC Single-target Drugs Sales by Type
2.2.6.1 Global FIC Single-target Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global FIC Single-target Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global FIC Single-target Drugs Sale Price by Type (2021-2026)
2.3 FIC Single-target Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 FIC Single-target Drugs Sales by Application
2.3.4.1 Global FIC Single-target Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global FIC Single-target Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global FIC Single-target Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global FIC Single-target Drugs Breakdown Data by Company
3.1.1 Global FIC Single-target Drugs Annual Sales by Company (2021-2026)
3.1.2 Global FIC Single-target Drugs Sales Market Share by Company (2021-2026)
3.2 Global FIC Single-target Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global FIC Single-target Drugs Revenue by Company (2021-2026)
3.2.2 Global FIC Single-target Drugs Revenue Market Share by Company (2021-2026)
3.3 Global FIC Single-target Drugs Sale Price by Company
3.4 Key Manufacturers FIC Single-target Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers FIC Single-target Drugs Product Location Distribution
3.4.2 Players FIC Single-target Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIC SINGLE-TARGET DRUGS BY GEOGRAPHIC REGION
4.1 World Historic FIC Single-target Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global FIC Single-target Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global FIC Single-target Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic FIC Single-target Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global FIC Single-target Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global FIC Single-target Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas FIC Single-target Drugs Sales Growth
4.4 APAC FIC Single-target Drugs Sales Growth
4.5 Europe FIC Single-target Drugs Sales Growth
4.6 Middle East & Africa FIC Single-target Drugs Sales Growth
5 AMERICAS
5.1 Americas FIC Single-target Drugs Sales by Country
5.1.1 Americas FIC Single-target Drugs Sales by Country (2021-2026)
5.1.2 Americas FIC Single-target Drugs Revenue by Country (2021-2026)
5.2 Americas FIC Single-target Drugs Sales by Type (2021-2026)
5.3 Americas FIC Single-target Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC FIC Single-target Drugs Sales by Region
6.1.1 APAC FIC Single-target Drugs Sales by Region (2021-2026)
6.1.2 APAC FIC Single-target Drugs Revenue by Region (2021-2026)
6.2 APAC FIC Single-target Drugs Sales by Type (2021-2026)
6.3 APAC FIC Single-target Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe FIC Single-target Drugs by Country
7.1.1 Europe FIC Single-target Drugs Sales by Country (2021-2026)
7.1.2 Europe FIC Single-target Drugs Revenue by Country (2021-2026)
7.2 Europe FIC Single-target Drugs Sales by Type (2021-2026)
7.3 Europe FIC Single-target Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa FIC Single-target Drugs by Country
8.1.1 Middle East & Africa FIC Single-target Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa FIC Single-target Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa FIC Single-target Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa FIC Single-target Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of FIC Single-target Drugs
10.3 Manufacturing Process Analysis of FIC Single-target Drugs
10.4 Industry Chain Structure of FIC Single-target Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 FIC Single-target Drugs Distributors
11.3 FIC Single-target Drugs Customer
12 WORLD FORECAST REVIEW FOR FIC SINGLE-TARGET DRUGS BY GEOGRAPHIC REGION
12.1 Global FIC Single-target Drugs Market Size Forecast by Region
12.1.1 Global FIC Single-target Drugs Forecast by Region (2027-2032)
12.1.2 Global FIC Single-target Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global FIC Single-target Drugs Forecast by Type (2027-2032)
12.7 Global FIC Single-target Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer FIC Single-target Drugs Product Portfolios and Specifications
13.1.3 Pfizer FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson FIC Single-target Drugs Product Portfolios and Specifications
13.2.3 Johnson & Johnson FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck FIC Single-target Drugs Product Portfolios and Specifications
13.3.3 Merck FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche FIC Single-target Drugs Product Portfolios and Specifications
13.4.3 Roche FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis FIC Single-target Drugs Product Portfolios and Specifications
13.5.3 Novartis FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 BMS
13.6.1 BMS Company Information
13.6.2 BMS FIC Single-target Drugs Product Portfolios and Specifications
13.6.3 BMS FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BMS Main Business Overview
13.6.5 BMS Latest Developments
13.7 ImmunoGen
13.7.1 ImmunoGen Company Information
13.7.2 ImmunoGen FIC Single-target Drugs Product Portfolios and Specifications
13.7.3 ImmunoGen FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ImmunoGen Main Business Overview
13.7.5 ImmunoGen Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi FIC Single-target Drugs Product Portfolios and Specifications
13.8.3 Sanofi FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Immunocore
13.9.1 Immunocore Company Information
13.9.2 Immunocore FIC Single-target Drugs Product Portfolios and Specifications
13.9.3 Immunocore FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Immunocore Main Business Overview
13.9.5 Immunocore Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech FIC Single-target Drugs Product Portfolios and Specifications
13.10.3 Genentech FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly FIC Single-target Drugs Product Portfolios and Specifications
13.11.3 Eli Lilly FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Agios
13.12.1 Agios Company Information
13.12.2 Agios FIC Single-target Drugs Product Portfolios and Specifications
13.12.3 Agios FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Agios Main Business Overview
13.12.5 Agios Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim FIC Single-target Drugs Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Gilead
13.14.1 Gilead Company Information
13.14.2 Gilead FIC Single-target Drugs Product Portfolios and Specifications
13.14.3 Gilead FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Gilead Main Business Overview
13.14.5 Gilead Latest Developments
13.15 Mallinckrodt
13.15.1 Mallinckrodt Company Information
13.15.2 Mallinckrodt FIC Single-target Drugs Product Portfolios and Specifications
13.15.3 Mallinckrodt FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Mallinckrodt Main Business Overview
13.15.5 Mallinckrodt Latest Developments
13.16 Phathom
13.16.1 Phathom Company Information
13.16.2 Phathom FIC Single-target Drugs Product Portfolios and Specifications
13.16.3 Phathom FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Phathom Main Business Overview
13.16.5 Phathom Latest Developments
13.17 Dermavant Sciences
13.17.1 Dermavant Sciences Company Information
13.17.2 Dermavant Sciences FIC Single-target Drugs Product Portfolios and Specifications
13.17.3 Dermavant Sciences FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Dermavant Sciences Main Business Overview
13.17.5 Dermavant Sciences Latest Developments
13.18 Polarean lmaging
13.18.1 Polarean lmaging Company Information
13.18.2 Polarean lmaging FIC Single-target Drugs Product Portfolios and Specifications
13.18.3 Polarean lmaging FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Polarean lmaging Main Business Overview
13.18.5 Polarean lmaging Latest Developments
13.19 Marinus
13.19.1 Marinus Company Information
13.19.2 Marinus FIC Single-target Drugs Product Portfolios and Specifications
13.19.3 Marinus FIC Single-target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Marinus Main Business Overview
13.19.5 Marinus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. FIC Single-target Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. FIC Single-target Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of ROR? Covalent Inhibitors
Table 4. Major Players of Citron Inhibitors
Table 5. Major Players of ALK2 Inhibitors
Table 6. Major Players of GCN2 Agonists
Table 7. Major Players of Others
Table 8. Global FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Table 10. Global FIC Single-target Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global FIC Single-target Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global FIC Single-target Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global FIC Single-target Drugs Sale Market Share by Application (2021-2026)
Table 15. Global FIC Single-target Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global FIC Single-target Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global FIC Single-target Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global FIC Single-target Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global FIC Single-target Drugs Sales Market Share by Company (2021-2026)
Table 20. Global FIC Single-target Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global FIC Single-target Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global FIC Single-target Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers FIC Single-target Drugs Producing Area Distribution and Sales Area
Table 24. Players FIC Single-target Drugs Products Offered
Table 25. FIC Single-target Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global FIC Single-target Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global FIC Single-target Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global FIC Single-target Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global FIC Single-target Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global FIC Single-target Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global FIC Single-target Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global FIC Single-target Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global FIC Single-target Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas FIC Single-target Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas FIC Single-target Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas FIC Single-target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC FIC Single-target Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC FIC Single-target Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC FIC Single-target Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe FIC Single-target Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe FIC Single-target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa FIC Single-target Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa FIC Single-target Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of FIC Single-target Drugs
Table 55. Key Market Challenges & Risks of FIC Single-target Drugs
Table 56. Key Industry Trends of FIC Single-target Drugs
Table 57. FIC Single-target Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. FIC Single-target Drugs Distributors List
Table 60. FIC Single-target Drugs Customer List
Table 61. Global FIC Single-target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global FIC Single-target Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas FIC Single-target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas FIC Single-target Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC FIC Single-target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC FIC Single-target Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe FIC Single-target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe FIC Single-target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa FIC Single-target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa FIC Single-target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global FIC Single-target Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global FIC Single-target Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global FIC Single-target Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global FIC Single-target Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer FIC Single-target Drugs Product Portfolios and Specifications
Table 77. Pfizer FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Johnson & Johnson Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson & Johnson FIC Single-target Drugs Product Portfolios and Specifications
Table 82. Johnson & Johnson FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Johnson & Johnson Main Business
Table 84. Johnson & Johnson Latest Developments
Table 85. Merck Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck FIC Single-target Drugs Product Portfolios and Specifications
Table 87. Merck FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Roche Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Roche FIC Single-target Drugs Product Portfolios and Specifications
Table 92. Roche FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Roche Main Business
Table 94. Roche Latest Developments
Table 95. Novartis Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis FIC Single-target Drugs Product Portfolios and Specifications
Table 97. Novartis FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. BMS Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. BMS FIC Single-target Drugs Product Portfolios and Specifications
Table 102. BMS FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. BMS Main Business
Table 104. BMS Latest Developments
Table 105. ImmunoGen Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. ImmunoGen FIC Single-target Drugs Product Portfolios and Specifications
Table 107. ImmunoGen FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. ImmunoGen Main Business
Table 109. ImmunoGen Latest Developments
Table 110. Sanofi Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Sanofi FIC Single-target Drugs Product Portfolios and Specifications
Table 112. Sanofi FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Sanofi Main Business
Table 114. Sanofi Latest Developments
Table 115. Immunocore Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Immunocore FIC Single-target Drugs Product Portfolios and Specifications
Table 117. Immunocore FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Immunocore Main Business
Table 119. Immunocore Latest Developments
Table 120. Genentech Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Genentech FIC Single-target Drugs Product Portfolios and Specifications
Table 122. Genentech FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Genentech Main Business
Table 124. Genentech Latest Developments
Table 125. Eli Lilly Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Eli Lilly FIC Single-target Drugs Product Portfolios and Specifications
Table 127. Eli Lilly FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Eli Lilly Main Business
Table 129. Eli Lilly Latest Developments
Table 130. Agios Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Agios FIC Single-target Drugs Product Portfolios and Specifications
Table 132. Agios FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Agios Main Business
Table 134. Agios Latest Developments
Table 135. Boehringer Ingelheim Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Boehringer Ingelheim FIC Single-target Drugs Product Portfolios and Specifications
Table 137. Boehringer Ingelheim FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Boehringer Ingelheim Main Business
Table 139. Boehringer Ingelheim Latest Developments
Table 140. Gilead Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Gilead FIC Single-target Drugs Product Portfolios and Specifications
Table 142. Gilead FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Gilead Main Business
Table 144. Gilead Latest Developments
Table 145. Mallinckrodt Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Mallinckrodt FIC Single-target Drugs Product Portfolios and Specifications
Table 147. Mallinckrodt FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Mallinckrodt Main Business
Table 149. Mallinckrodt Latest Developments
Table 150. Phathom Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Phathom FIC Single-target Drugs Product Portfolios and Specifications
Table 152. Phathom FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Phathom Main Business
Table 154. Phathom Latest Developments
Table 155. Dermavant Sciences Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Dermavant Sciences FIC Single-target Drugs Product Portfolios and Specifications
Table 157. Dermavant Sciences FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Dermavant Sciences Main Business
Table 159. Dermavant Sciences Latest Developments
Table 160. Polarean lmaging Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Polarean lmaging FIC Single-target Drugs Product Portfolios and Specifications
Table 162. Polarean lmaging FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Polarean lmaging Main Business
Table 164. Polarean lmaging Latest Developments
Table 165. Marinus Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Marinus FIC Single-target Drugs Product Portfolios and Specifications
Table 167. Marinus FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Marinus Main Business
Table 169. Marinus Latest Developments
Table 1. FIC Single-target Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. FIC Single-target Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of ROR? Covalent Inhibitors
Table 4. Major Players of Citron Inhibitors
Table 5. Major Players of ALK2 Inhibitors
Table 6. Major Players of GCN2 Agonists
Table 7. Major Players of Others
Table 8. Global FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Table 10. Global FIC Single-target Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global FIC Single-target Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global FIC Single-target Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global FIC Single-target Drugs Sale Market Share by Application (2021-2026)
Table 15. Global FIC Single-target Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global FIC Single-target Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global FIC Single-target Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global FIC Single-target Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global FIC Single-target Drugs Sales Market Share by Company (2021-2026)
Table 20. Global FIC Single-target Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global FIC Single-target Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global FIC Single-target Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers FIC Single-target Drugs Producing Area Distribution and Sales Area
Table 24. Players FIC Single-target Drugs Products Offered
Table 25. FIC Single-target Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global FIC Single-target Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global FIC Single-target Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global FIC Single-target Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global FIC Single-target Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global FIC Single-target Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global FIC Single-target Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global FIC Single-target Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global FIC Single-target Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas FIC Single-target Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas FIC Single-target Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas FIC Single-target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC FIC Single-target Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC FIC Single-target Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC FIC Single-target Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe FIC Single-target Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe FIC Single-target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa FIC Single-target Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa FIC Single-target Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa FIC Single-target Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa FIC Single-target Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of FIC Single-target Drugs
Table 55. Key Market Challenges & Risks of FIC Single-target Drugs
Table 56. Key Industry Trends of FIC Single-target Drugs
Table 57. FIC Single-target Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. FIC Single-target Drugs Distributors List
Table 60. FIC Single-target Drugs Customer List
Table 61. Global FIC Single-target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global FIC Single-target Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas FIC Single-target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas FIC Single-target Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC FIC Single-target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC FIC Single-target Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe FIC Single-target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe FIC Single-target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa FIC Single-target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa FIC Single-target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global FIC Single-target Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global FIC Single-target Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global FIC Single-target Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global FIC Single-target Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer FIC Single-target Drugs Product Portfolios and Specifications
Table 77. Pfizer FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Johnson & Johnson Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson & Johnson FIC Single-target Drugs Product Portfolios and Specifications
Table 82. Johnson & Johnson FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Johnson & Johnson Main Business
Table 84. Johnson & Johnson Latest Developments
Table 85. Merck Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck FIC Single-target Drugs Product Portfolios and Specifications
Table 87. Merck FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Roche Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Roche FIC Single-target Drugs Product Portfolios and Specifications
Table 92. Roche FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Roche Main Business
Table 94. Roche Latest Developments
Table 95. Novartis Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis FIC Single-target Drugs Product Portfolios and Specifications
Table 97. Novartis FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. BMS Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. BMS FIC Single-target Drugs Product Portfolios and Specifications
Table 102. BMS FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. BMS Main Business
Table 104. BMS Latest Developments
Table 105. ImmunoGen Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. ImmunoGen FIC Single-target Drugs Product Portfolios and Specifications
Table 107. ImmunoGen FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. ImmunoGen Main Business
Table 109. ImmunoGen Latest Developments
Table 110. Sanofi Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Sanofi FIC Single-target Drugs Product Portfolios and Specifications
Table 112. Sanofi FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Sanofi Main Business
Table 114. Sanofi Latest Developments
Table 115. Immunocore Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Immunocore FIC Single-target Drugs Product Portfolios and Specifications
Table 117. Immunocore FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Immunocore Main Business
Table 119. Immunocore Latest Developments
Table 120. Genentech Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Genentech FIC Single-target Drugs Product Portfolios and Specifications
Table 122. Genentech FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Genentech Main Business
Table 124. Genentech Latest Developments
Table 125. Eli Lilly Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Eli Lilly FIC Single-target Drugs Product Portfolios and Specifications
Table 127. Eli Lilly FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Eli Lilly Main Business
Table 129. Eli Lilly Latest Developments
Table 130. Agios Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Agios FIC Single-target Drugs Product Portfolios and Specifications
Table 132. Agios FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Agios Main Business
Table 134. Agios Latest Developments
Table 135. Boehringer Ingelheim Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Boehringer Ingelheim FIC Single-target Drugs Product Portfolios and Specifications
Table 137. Boehringer Ingelheim FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Boehringer Ingelheim Main Business
Table 139. Boehringer Ingelheim Latest Developments
Table 140. Gilead Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Gilead FIC Single-target Drugs Product Portfolios and Specifications
Table 142. Gilead FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Gilead Main Business
Table 144. Gilead Latest Developments
Table 145. Mallinckrodt Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Mallinckrodt FIC Single-target Drugs Product Portfolios and Specifications
Table 147. Mallinckrodt FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Mallinckrodt Main Business
Table 149. Mallinckrodt Latest Developments
Table 150. Phathom Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Phathom FIC Single-target Drugs Product Portfolios and Specifications
Table 152. Phathom FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Phathom Main Business
Table 154. Phathom Latest Developments
Table 155. Dermavant Sciences Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Dermavant Sciences FIC Single-target Drugs Product Portfolios and Specifications
Table 157. Dermavant Sciences FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Dermavant Sciences Main Business
Table 159. Dermavant Sciences Latest Developments
Table 160. Polarean lmaging Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Polarean lmaging FIC Single-target Drugs Product Portfolios and Specifications
Table 162. Polarean lmaging FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Polarean lmaging Main Business
Table 164. Polarean lmaging Latest Developments
Table 165. Marinus Basic Information, FIC Single-target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Marinus FIC Single-target Drugs Product Portfolios and Specifications
Table 167. Marinus FIC Single-target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Marinus Main Business
Table 169. Marinus Latest Developments
LIST OF FIGURES
Figure 1. Picture of FIC Single-target Drugs
Figure 2. FIC Single-target Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global FIC Single-target Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global FIC Single-target Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. FIC Single-target Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. FIC Single-target Drugs Sales Market Share by Country/Region (2025)
Figure 10. FIC Single-target Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of ROR? Covalent Inhibitors
Figure 12. Product Picture of Citron Inhibitors
Figure 13. Product Picture of ALK2 Inhibitors
Figure 14. Product Picture of GCN2 Agonists
Figure 15. Product Picture of Others
Figure 16. Global FIC Single-target Drugs Sales Market Share by Type in 2026
Figure 17. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2026)
Figure 18. FIC Single-target Drugs Consumed in Hospital
Figure 19. Global FIC Single-target Drugs Market: Hospital (2021-2026) & (K Units)
Figure 20. FIC Single-target Drugs Consumed in Clinic
Figure 21. Global FIC Single-target Drugs Market: Clinic (2021-2026) & (K Units)
Figure 22. FIC Single-target Drugs Consumed in Other
Figure 23. Global FIC Single-target Drugs Market: Other (2021-2026) & (K Units)
Figure 24. Global FIC Single-target Drugs Sale Market Share by Application (2025)
Figure 25. Global FIC Single-target Drugs Revenue Market Share by Application in 2026
Figure 26. FIC Single-target Drugs Sales by Company in 2026 (K Units)
Figure 27. Global FIC Single-target Drugs Sales Market Share by Company in 2026
Figure 28. FIC Single-target Drugs Revenue by Company in 2026 ($ millions)
Figure 29. Global FIC Single-target Drugs Revenue Market Share by Company in 2026
Figure 30. Global FIC Single-target Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global FIC Single-target Drugs Revenue Market Share by Geographic Region in 2026
Figure 32. Americas FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 33. Americas FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 34. APAC FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 35. APAC FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 36. Europe FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 37. Europe FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 40. Americas FIC Single-target Drugs Sales Market Share by Country in 2026
Figure 41. Americas FIC Single-target Drugs Revenue Market Share by Country (2021-2026)
Figure 42. Americas FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 43. Americas FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 44. United States FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC FIC Single-target Drugs Sales Market Share by Region in 2026
Figure 49. APAC FIC Single-target Drugs Revenue Market Share by Region (2021-2026)
Figure 50. APAC FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 51. APAC FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 52. China FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. India FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe FIC Single-target Drugs Sales Market Share by Country in 2026
Figure 60. Europe FIC Single-target Drugs Revenue Market Share by Country (2021-2026)
Figure 61. Europe FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 62. Europe FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 63. Germany FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. France FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. UK FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa FIC Single-target Drugs Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 71. Egypt FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of FIC Single-target Drugs in 2026
Figure 77. Manufacturing Process Analysis of FIC Single-target Drugs
Figure 78. Industry Chain Structure of FIC Single-target Drugs
Figure 79. Channels of Distribution
Figure 80. Global FIC Single-target Drugs Sales Market Forecast by Region (2027-2032)
Figure 81. Global FIC Single-target Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global FIC Single-target Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global FIC Single-target Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global FIC Single-target Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global FIC Single-target Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of FIC Single-target Drugs
Figure 2. FIC Single-target Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global FIC Single-target Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global FIC Single-target Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. FIC Single-target Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. FIC Single-target Drugs Sales Market Share by Country/Region (2025)
Figure 10. FIC Single-target Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of ROR? Covalent Inhibitors
Figure 12. Product Picture of Citron Inhibitors
Figure 13. Product Picture of ALK2 Inhibitors
Figure 14. Product Picture of GCN2 Agonists
Figure 15. Product Picture of Others
Figure 16. Global FIC Single-target Drugs Sales Market Share by Type in 2026
Figure 17. Global FIC Single-target Drugs Revenue Market Share by Type (2021-2026)
Figure 18. FIC Single-target Drugs Consumed in Hospital
Figure 19. Global FIC Single-target Drugs Market: Hospital (2021-2026) & (K Units)
Figure 20. FIC Single-target Drugs Consumed in Clinic
Figure 21. Global FIC Single-target Drugs Market: Clinic (2021-2026) & (K Units)
Figure 22. FIC Single-target Drugs Consumed in Other
Figure 23. Global FIC Single-target Drugs Market: Other (2021-2026) & (K Units)
Figure 24. Global FIC Single-target Drugs Sale Market Share by Application (2025)
Figure 25. Global FIC Single-target Drugs Revenue Market Share by Application in 2026
Figure 26. FIC Single-target Drugs Sales by Company in 2026 (K Units)
Figure 27. Global FIC Single-target Drugs Sales Market Share by Company in 2026
Figure 28. FIC Single-target Drugs Revenue by Company in 2026 ($ millions)
Figure 29. Global FIC Single-target Drugs Revenue Market Share by Company in 2026
Figure 30. Global FIC Single-target Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global FIC Single-target Drugs Revenue Market Share by Geographic Region in 2026
Figure 32. Americas FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 33. Americas FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 34. APAC FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 35. APAC FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 36. Europe FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 37. Europe FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa FIC Single-target Drugs Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa FIC Single-target Drugs Revenue 2021-2026 ($ millions)
Figure 40. Americas FIC Single-target Drugs Sales Market Share by Country in 2026
Figure 41. Americas FIC Single-target Drugs Revenue Market Share by Country (2021-2026)
Figure 42. Americas FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 43. Americas FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 44. United States FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC FIC Single-target Drugs Sales Market Share by Region in 2026
Figure 49. APAC FIC Single-target Drugs Revenue Market Share by Region (2021-2026)
Figure 50. APAC FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 51. APAC FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 52. China FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. India FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe FIC Single-target Drugs Sales Market Share by Country in 2026
Figure 60. Europe FIC Single-target Drugs Revenue Market Share by Country (2021-2026)
Figure 61. Europe FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 62. Europe FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 63. Germany FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. France FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. UK FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa FIC Single-target Drugs Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa FIC Single-target Drugs Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa FIC Single-target Drugs Sales Market Share by Application (2021-2026)
Figure 71. Egypt FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries FIC Single-target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of FIC Single-target Drugs in 2026
Figure 77. Manufacturing Process Analysis of FIC Single-target Drugs
Figure 78. Industry Chain Structure of FIC Single-target Drugs
Figure 79. Channels of Distribution
Figure 80. Global FIC Single-target Drugs Sales Market Forecast by Region (2027-2032)
Figure 81. Global FIC Single-target Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global FIC Single-target Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global FIC Single-target Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global FIC Single-target Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global FIC Single-target Drugs Revenue Market Share Forecast by Application (2027-2032)
